Annabel Samimy

Stock Analyst at Stifel

(3.34)
# 922
Out of 4,884 analysts
56
Total ratings
40.43%
Success rate
24.82%
Average return

Stocks Rated by Annabel Samimy

Ligand Pharmaceuticals
Apr 10, 2025
Initiates: Buy
Price Target: $143
Current: $113.30
Upside: +26.21%
Palvella Therapeutics
Mar 26, 2025
Initiates: Buy
Price Target: $45
Current: $23.70
Upside: +89.87%
Structure Therapeutics
Jan 8, 2025
Initiates: Buy
Price Target: $50
Current: $20.44
Upside: +144.62%
Altimmune
Jan 8, 2025
Initiates: Buy
Price Target: $18
Current: $4.90
Upside: +267.35%
Inventiva
Nov 22, 2024
Maintains: Buy
Price Target: $20$17
Current: $2.98
Upside: +470.47%
MBX Biosciences
Oct 8, 2024
Initiates: Buy
Price Target: $40
Current: $12.33
Upside: +224.41%
Kamada
Jul 3, 2024
Initiates: Buy
Price Target: $18
Current: $7.74
Upside: +132.56%
Phathom Pharmaceuticals
May 3, 2024
Initiates: Buy
Price Target: $24
Current: $8.91
Upside: +169.36%
REGENXBIO
Apr 12, 2024
Maintains: Buy
Price Target: $40
Current: $8.62
Upside: +364.04%
Viking Therapeutics
Mar 15, 2024
Reiterates: Buy
Price Target: $80
Current: $27.72
Upside: +188.60%
Maintains: Buy
Price Target: $225$230
Current: $109.92
Upside: +109.24%
Reiterates: Buy
Price Target: $23$25
Current: $9.21
Upside: +171.44%
Initiates: Buy
Price Target: $35
Current: $18.97
Upside: +84.50%
Maintains: Buy
Price Target: $60$65
Current: $17.82
Upside: +264.76%
Downgrades: Hold
Price Target: $700$275
Current: $5.25
Upside: +5,138.10%
Initiates: Buy
Price Target: $45
Current: $14.29
Upside: +214.91%
Upgrades: Buy
Price Target: $8
Current: $0.81
Upside: +892.56%
Initiates: Buy
Price Target: $24
Current: $0.53
Upside: +4,412.97%
Initiates: Hold
Price Target: $20
Current: $29.63
Upside: -32.50%
Maintains: Buy
Price Target: $700$750
Current: $1.14
Upside: +65,689.47%
Maintains: Hold
Price Target: $25$24
Current: $32.07
Upside: -25.16%
Maintains: Hold
Price Target: $15$21
Current: $0.67
Upside: +3,025.00%